Stocks · Health care · Pharmaceutical Preparations

Keros Therapeutics, Inc.

KROS Clue Score73

United States Fiscal year ends December CIK 0001664710 Results filed 5 Nov 2026

Add to watchlist

What the insiders did Net selling

Bought (120 mo)

$55.73M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$242.31M

$95.67K on a plan · $10.38M straight out of an exercise

Sold at will

$231.83M

274 of 351 sales

Net

−$186.58M

−$176.10M against sales at will